Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.

Engelhard M, Wingen-Heimann SM, Classen AY, Blau IW, Bug G, Hebermehl C, Kraus S, Penack O, Rettig AR, Schmitt T, Steinbrunn T, Teschner D, Vehreschild MJGT, Wehr C, Vehreschild JJ, Pütz SM

Open source

DOI
10.1007/s10198-025-01890-4
Published
2026 Feb 16
Container
The European journal of health economics : HEPAC : health economics in prevention and care
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10198-025-01890-4,
  title = {Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.},
  author = {Engelhard M and Wingen-Heimann SM and Classen AY and Blau IW and Bug G and Hebermehl C and Kraus S and Penack O and Rettig AR and Schmitt T and Steinbrunn T and Teschner D and Vehreschild MJGT and Wehr C and Vehreschild JJ and Pütz SM},
  year = {2026},
  journal = {The European journal of health economics : HEPAC : health economics in prevention and care},
  doi = {10.1007/s10198-025-01890-4},
  url = {https://doi.org/10.1007/s10198-025-01890-4}
}

RIS

TY  - JOUR
TI  - Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
AU  - Engelhard M
AU  - Wingen-Heimann SM
AU  - Classen AY
AU  - Blau IW
AU  - Bug G
AU  - Hebermehl C
AU  - Kraus S
AU  - Penack O
AU  - Rettig AR
AU  - Schmitt T
AU  - Steinbrunn T
AU  - Teschner D
AU  - Vehreschild MJGT
AU  - Wehr C
AU  - Vehreschild JJ
AU  - Pütz SM
PY  - 2026
JO  - The European journal of health economics : HEPAC : health economics in prevention and care
DO  - 10.1007/s10198-025-01890-4
UR  - https://doi.org/10.1007/s10198-025-01890-4
ER  - 

APA

M, E., SM, W., AY, C., IW, B., G, B., C, H., S, K., O, P., AR, R., T, S., T, S., D, T., MJGT, V., C, W., JJ, V., & SM, P. (2026). Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.. The European journal of health economics : HEPAC : health economics in prevention and care. https://doi.org/10.1007/s10198-025-01890-4

Source records